CRGY,Crescent Energy Company | Energy

Energy

CRGY

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

Crescent Energy CompanyCRGY

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

% Change

Description >

Crescent Energy Company, an energy company, acquires, develops, and produces crude oil, natural gas, and natural gas liquids (NGLs) reserves.

The company holds a portfolio of oil and natural gas assets in key proven basins, including the Eagle Ford, Rockies, Barnett, Permian, and Mid-Con in the United States.

The company is based in Houston, Texas.

Latest News >

Update: Market Chatter: Alphabet's Google May Face New EU Probe Over News Publisher Rankings

Nov 13, 2025

10:09 AM EST, 11/13/2025 (MT Newswires) -- (Updates with Google's ( GOOG ) response in fourth paragraph.) Alphabet's (GOOG, GOOGL) Google ( GOOG ) is set to face a new investigation by the European Commission into how it ranks news publishers in search results, the Financial Times reported Wednesday, citing officials familiar with the matter. The inquiry will examine claims...

DoorDash, Coco Robotics Expand Autonomous Deliveries Partnership

Nov 13, 2025

10:06 AM EST, 11/13/2025 (MT Newswires) -- DoorDash ( DASH ) and Coco Robotics have broadened their partnership to scale autonomous deliveries across Los Angeles and Chicago, and to expand into Miami, the companies said Thursday. Coco Robotics will now support deliveries on behalf of national grocers and retailers for the first time via the DashMart Fulfillment Services, the companies...

Stratasys Q3 Revenue Growth Driven By Strong Customer Engagement

Nov 13, 2025

Stratasys shares were trading higher during premarket on Thursday after the company reported third-quarter FY25 results. Details The company clocked a quarterly revenue of $137.0 million, beating the analyst consensus estimate of $136.6 million. The adjusted gross margin declined to 45.3% from 49.6% a year ago. Adjusted operating income was $0.1 million for the period, compared to an operating loss of $0.1 million in the same period the previous year. Adjusted net...

Analysis-Novo Nordisk CEO signals new appetite for risk in obesity deals

Nov 13, 2025

NEW YORK/LONDON (Reuters) -When Novo Nordisk CEO Mike Doustdar learned in late September that Metsera had accepted a $7.3 billion rival bid from Pfizer, he was not ready to give up just yet on the company and its portfolio of experimental obesity drugs. Facing pressure to show results after taking the helm of the Danish drugmaker in August, Doustdar had...